Parabilis Medicines, Inc. (PBLS)

38.33 -0.90 (-2.29%) USD  |  NASDAQ  |  Aug 26, 14:54
More

Parabilis Medicines EPS Estimates for 2 Fiscal Years Ahead

EPS Estimates for 2 Fiscal Years Ahead Chart

View EPS Estimates for 2 Fiscal Years Ahead for PBLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for 2 Fiscal Years Ahead Chart
Start Trial

Historical EPS Estimates for 2 Fiscal Years Ahead Data

View and export this data back to . Start Trial.
Date Value

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years

View EPS Estimates for 2 Fiscal Years Ahead Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for 2 Fiscal Years Ahead Benchmarks

View EPS Estimates for 2 Fiscal Years Ahead Benchmarks
Start Trial
Moderna, Inc. Upgrade
Kailera Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade